Sugar-Sweetened and Artificially Sweetened Beverages in Relation to Stroke and Dementia
Stroke Diagnosis in the Pediatric Emergency Department
Hypertroponinemia, Structural Cardiac Disease, and Stroke Mortality
Proposed International Classification of Diseases Eleventh Revision Classification and Its Effects on Stroke Unit Care
Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia
GRECOS Project (Genotyping Recurrence Risk of Stroke)
Bilirubin and Stroke Risk Using a Mendelian Randomization Design
Risk of Stroke in Patients With Heart Failure
Stroke in Indigenous Africans, African Americans, and European Americans
Changes in the Employment Status and Risk of Stroke and Stroke Types
Homocysteine and Stroke Risk
Ambient PM2.5 and Stroke
Accuracy and Reliability of Stroke Diagnosis in the Pediatric Emergency Department
Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke
Aspirin and Risk of Subarachnoid Hemorrhage
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke
Associations of Ischemic Lesion Volume With Functional Outcome in Patients With Acute Ischemic Stroke
Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging After Acute Ischemic Stroke of Undetermined Origin
Primary Angiitis of the Central Nervous System
Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)
Computed Tomographic Perfusion Selection and Clinical Outcomes After Endovascular Therapy in Large Vessel Occlusion Stroke
Vascular Anatomy Predicts the Risk of Cerebral Ischemia in Patients Randomized to Carotid Stenting Versus Endarterectomy
MIDAS (Modafinil in Debilitating Fatigue After Stroke)
Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke
Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation
Transfer to High-Volume Centers Associated With Reduced Mortality After Endovascular Treatment of Acute Stroke
Use of Platelet Function Testing Before Pipeline Embolization Device Placement
Mortality Reduction for Fever, Hyperglycemia, and Swallowing Nurse-Initiated Stroke Intervention
Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes)
Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation
Googling Service Boundaries for Endovascular Clot Retrieval Hub Hospitals in a Metropolitan Setting
Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress
CD163 Expression in Neurons After Experimental Intracerebral Hemorrhage
Quantitative Imaging of Cerebral Thromboemboli In Vivo
Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke
A Dedicated Spanish Language Line Increases Enrollment of Hispanics Into Prehospital Clinical Research
Silent Brain Infarctions and Leukoaraiosis in Patients With Retinal Ischemia
Predictors of Dysphagia in Acute Pontine Infarction
Proportional Recovery From Lower Limb Motor Impairment After Stroke
Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease
Focal Macroscopic Cortical Lesions in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
RECAST (Remote Ischemic Conditioning After Stroke Trial)
Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Soluble FLT1 Gene Therapy Alleviates Brain Arteriovenous Malformation Severity
Intracranial Dural Arteriovenous Fistulae
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents
Aspirin’s Benefits Were Previously Underestimated and Are Primarily Accrued in the Acute Setting
Update on the State of the Evidence for Stroke Family Caregiver and Dyad Interventions
Patient With Severe Moyamoya Disease Who Presents With Acute Cortical Blindness
Letter by Kawada Regarding Article, “Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke
Letter by Behrouz and Aachi Regarding Article, “Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke
Response by Falkstedt et al to Letters Regarding Article, “Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke
Letter by Castilla-Guerra et al Regarding Article, “Pioglitazone for Secondary Stroke Prevention
Response by Lee and Ovbiagele to Letter Regarding Article, “Pioglitazone for Secondary Stroke Prevention
Correction to
Correction to